Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia) - correlations between clinical and morphological features
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- Vol. 415 (3) , 191-202
- https://doi.org/10.1007/bf00724905
Abstract
Histomorphometry was performed on representative trephine biopsies of the bone marrow on admission of 50 patients (21 male, 29 female-age 67 years) with so-called primary osteomyelofibrosis/-sclerosis (OMF) not preceded by any other subtype of chronic myeloproliferative disorders. This study was firstly aimed at testing correlations between histological features (amount of haematopoiesis, cytological aspects of mega-karyocytes, density of reticulin and collagen fibres and degree of osteosclerosis) and laboratory data, as well as spleen size and duration of relevant prediagnostic symptoms. Secondly, we concentrated on a discrimination of OMF patients into two sub-groups according to bone marrow morphology and clinical variables. Statistical evaluation of histomorphometric variables and haematological findings disclosed that there was a progressive fibro-osteosclerotic process in the evolution of disease features. Increase in medullary fibrosis was significantly paralleled by an abnormal or pleomorphic megakaryopoiesis in the bone marrow: there was an increase in irregularity of perimeters for megakaryocytes and naked nuclei combined with smaller sizes of these elements including the nuclei. Additionally, there was a greater number of pycnotic bare nuclei. A number of morphometric features (density of fibres, degree of osteosclerosis, amount of haematopoiesis) were associated with corresponding clinical data (spleen size, length of preclinical history). By consideration of a set of basic histomorphometric variables our co-hort of 50 patients could be divided into an early hyperplastic subtype with no or minimal medullary reticulin and another group with conspicuous fibrotic and osteosclerotic alterations of the bone marrow. It was noticeable that we found no significant correlation between amount of haematopoiesis or marrow cellularity with splenomegaly. This result suggests that splenic haematopoiesis (myeloid metaplasia) may represent an autonomous or neoplastic process and not only compensation for a failing fibro-osteosclerotic bone marrow.This publication has 42 references indexed in Scilit:
- MYELOFIBROSIS: PROGNOSTIC FACTORS AND TREATMENTBritish Journal of Haematology, 1988
- 1.25 DIHYDROXY-VITAMIN D5 (1.25 (OH), vit D3) IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSISBritish Journal of Haematology, 1987
- CLINICAL AND LABORATORY STUDIES OF 1,25-DIHYDROXYCHOLECALCIFEROL IN MYELOFIBROSISBritish Journal of Haematology, 1987
- 1,25‐DIHYDROXY‐VITAMIN D3 (1,25(OH)2D3) IN THE TREATMENT OF 1DIOPATHIC MYELOFIBROSISBritish Journal of Haematology, 1986
- Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings.Journal of Clinical Pathology, 1986
- THE USEFULNESS OF 1,25‐DIHYDROXY‐VITAMIN D3 (1,25(OH)2 vit D3) IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSISBritish Journal of Haematology, 1986
- Platelet factor‐4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosisBritish Journal of Haematology, 1984
- IDIOPATHIC MYELOFIBROSIS: A POSSIBLE ROLE OF IMMUNOLOGICAL PHENOMENABritish Journal of Haematology, 1982
- Myelofibrosis in Chronic Granulocytic LeukaemiaBritish Journal of Haematology, 1979
- Vorkommen von Tartrat-resistenter saurer Phosphatase in verschiedenen Zelltypen des lympho-retikul ren und h mopoetischen SystemsAnnals of Hematology, 1977